Rankings
▼
Calendar
VRTX FY 2023 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena
VRTX
Vertex Pharmaceuticals Incorporated
$129B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9.9B
+10.5% YoY
Gross Profit
$8.6B
87.2% margin
Operating Income
$3.8B
38.8% margin
Net Income
$3.6B
36.7% margin
EPS (Diluted)
$13.89
Cash Flow
Operating Cash Flow
$3.5B
Free Cash Flow
$3.3B
Stock-Based Comp.
$581M
Balance Sheet
Total Assets
$22.7B
Total Liabilities
$5.1B
Stockholders' Equity
$17.6B
Cash & Equivalents
$10.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9.9B
$8.9B
+10.5%
Gross Profit
$8.6B
$7.9B
+9.6%
Operating Income
$3.8B
$4.3B
-11.0%
Net Income
$3.6B
$3.3B
+9.0%
← Q4 2022
All Quarters
Q1 2023 →